Little could be done for children with duchin muscular dystrophy until the gene responsible

for the disease was known.

Hear about the possibilities geneticists are now exploring on the latest episode of Targeting

the Toughest Diseases, a new podcast by Bloomberg Media Studios and Vertex Pharmaceuticals.

This is Master's in Business with Barry Redholz on Bloomberg Radio.

This week on the podcast, what can I say Charlie Alice is a legend in the world of finance,

whether it was at Greenwich Associates or as chair of the Yale Endowment or a board member

at Vanguard.

He has seen pretty much everything in the world of investing.

His career spans the entire modern era dating back to the Pol-Volker era and what took

place during the boom periods of the 80s and 90s and how technology has changed the world

of investing.

He's just one of these people who is so thoughtful and insightful about everything.

It's just always a pleasure to chat with him.

I found our discussion to be absolutely fascinating and I think you will also with no further

ado, my conversation with Greenwich Associates, Charlie Alice.

The last time we spoke, we really were talking about the retirement crisis and we spent

a little bit of time discussing Vanguard but this new book is so interesting and so filled

with details that only an insider can have.

Let's delve into it a little bit, tell us what first led you to Vanguard.

How did you get involved with them?

Well, it started a little time ago, 1966.

...